Similar articles for PMID: 30858224

Year	Number of Results
2002	1
2003	1
2011	3
2012	5
2013	2
2014	1
2015	10
2016	9
2017	15
2018	21
2019	19
2020	7
2021	13
2022	3

1

You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease.

Umeukeje EM, Young BA, Fullerton SM, Cavanaugh K, Owens D, Wilson JG, Burke W, Blacksher E. Umeukeje EM, et al. J Am Soc Nephrol. 2019 Apr;30(4):526-530. doi: 10.1681/ASN.2018111091. Epub 2019 Mar 11. J Am Soc Nephrol. 2019. PMID: 30858224 Free PMC article. No abstract available.

2

African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study.

Gordon EJ, Amόrtegui D, Blancas I, Wicklund C, Friedewald J, Sharp RR. Gordon EJ, et al. Am J Kidney Dis. 2018 Dec;72(6):819-833. doi: 10.1053/j.ajkd.2018.07.017. Epub 2018 Oct 22. Am J Kidney Dis. 2018. PMID: 30360961 Free PMC article.

3

Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.

Young BA, Blacksher E, Cavanaugh KL, Freedman BI, Fullerton SM, Kopp JB, Umeukeje EM, West KM, Wilson JG, Burke W; APOL1 Stakeholders Project. Young BA, et al. Am J Nephrol. 2019;50(4):303-311. doi: 10.1159/000502675. Epub 2019 Sep 3. Am J Nephrol. 2019. PMID: 31480040 Free PMC article.

4

A Focus Group Study on African American Living Donors' Treatment Preferences, Sociocultural Factors, and Health Beliefs About Apolipoprotein L1 Genetic Testing.

Gordon EJ, Amórtegui D, Blancas I, Wicklund C, Friedewald J, Sharp RR. Gordon EJ, et al. Prog Transplant. 2019 Sep;29(3):239-247. doi: 10.1177/1526924819854485. Epub 2019 May 30. Prog Transplant. 2019. PMID: 31146624

5

Genetics and ESKD Disparities in African Americans.

Umeukeje EM, Young BA. Umeukeje EM, et al. Am J Kidney Dis. 2019 Dec;74(6):811-821. doi: 10.1053/j.ajkd.2019.06.006. Epub 2019 Oct 10. Am J Kidney Dis. 2019. PMID: 31606237 Free PMC article. Review.

6

African American living-kidney donors should be screened for APOL1 risk alleles.

Cohen DM, Mittalhenkle A, Scott DL, Young CJ, Norman DJ. Cohen DM, et al. Transplantation. 2011 Oct 15;92(7):722-5. doi: 10.1097/TP.0b013e31822eec39. Transplantation. 2011. PMID: 21878839 Free PMC article.

7

A National Survey of Transplant Surgeons and Nephrologists on Implementing Apolipoprotein L1 (APOL1) Genetic Testing Into Clinical Practice.

Gordon EJ, Wicklund C, Lee J, Sharp RR, Friedewald J. Gordon EJ, et al. Prog Transplant. 2019 Mar;29(1):26-35. doi: 10.1177/1526924818817048. Epub 2018 Dec 13. Prog Transplant. 2019. PMID: 30541404

8

Clinical Genetic Testing for APOL1: Are we There Yet?

Young BA, Fullerton SM, Wilson JG, Cavanaugh K, Blacksher E, Spigner C, Himmelfarb J, Burke W. Young BA, et al. Semin Nephrol. 2017 Nov;37(6):552-557. doi: 10.1016/j.semnephrol.2017.07.009. Semin Nephrol. 2017. PMID: 29110763 Free PMC article. Review.

9

Apolipoprotein L1 Gene Effects on Kidney Transplantation.

Freedman BI, Locke JE, Reeves-Daniel AM, Julian BA. Freedman BI, et al. Semin Nephrol. 2017 Nov;37(6):530-537. doi: 10.1016/j.semnephrol.2017.07.006. Semin Nephrol. 2017. PMID: 29110760 Free PMC article. Review.

10

Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.

Riella LV, Sheridan AM. Riella LV, et al. Am J Kidney Dis. 2015 Sep;66(3):396-401. doi: 10.1053/j.ajkd.2015.04.046. Epub 2015 Jun 3. Am J Kidney Dis. 2015. PMID: 26049628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed